Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: Potential, for a unique biological liver-assist device

Transplantation

Volumn 72, Issue 3, 2001, Pages 393-405

  Borie, Dominic C ^a,b,f   Eyraud, Daniel ^a,b   Boleslawski, Emmanuel ^a,b   Lemoine, Antoinette ^c   Sebagh, Mylène ^c   Cramer, Donald V ^d   Roussi, Jacqueline ^e   Imbert Bismut, Françoise ^a   Germain, Guy ^b   Hannoun, Laurent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CEMAGREF   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e RAYMOND POINCARÉ HOSPITAL   (France)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; INDOCYANINE GREEN; LACTIC ACID;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DEVICE; EXTRACORPOREAL CIRCULATION; GLUCOSE BLOOD LEVEL; INTEGRATED CIRCUIT; LIVER CELL; LIVER CIRCULATION; LIVER FUNCTION; LIVER INJURY; LIVER METABOLISM; LIVER PERFUSION; NONHUMAN; ORGAN DONOR; POROSITY; PRIORITY JOURNAL; SWINE;

EID: 0035881371     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108150-00007     Document Type: Article

References (54)

1. Artificial liver support in acute liver failure
2. The pig as a potential organ donor for man
3. Xenotransplantation
4. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure
5. The pathogenesis of the xenograft reaction
6. Xénotransplantation chez l'homme. I. Immunobiologie du rejet xénogénique
7. Xénotransplantation chez l'homme. II. Contrôle du rejet et application à la xénotransplantation de foie de porc chez l'homme
8. Genetic control of the humoral immune response to xenografts. II Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes
9. The humoral response to xenografts is controlled by a restricted repertoire of immunoglobulin VH genes
10. Molecular barriers to xenotransplantation
11. Orthotopic heart transplantation in a transgenic pig-to-primate model
12. Splenectomy improves survival of hDAF transgenic pig kidneys in primates
13. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy
14. A bioartificial liver to treat severe acute liver failure
15. Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial
16. Liver allotransplantation after extra-corporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus
17. Microbiological hazards related to xenotransplantation of porcine organs into man
18. Xenotransplantation and xenogeneic infections
19. Uncertainty in xenotransplantation: Individual benefit versus collective risk
20. Immunological studies in patients receiving repeated allogenic and xenogeneic liver hemoperfusions
21. Immunological observations in clinical heterologous (xenogeneic) liver perfusions
22. Heterologous liver perfusion in treatment of hepatic failure
23. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors
24. Influence du statut nutritionel du donneur sur la qualité du greffon hepatique. Interet de la restauration des reserves glycogeniques du donneur
25. Enzymatic determination of hydroxybutyric acid and acetoacetate in blood
26. Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis
27. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test
28. Significance of hepatic energy charge and blood ketone body ratio as a criteria of liver support. Indication and efficiency in hepatectomised patients during crossed dialysis
29. Determination of the ketone body ratio in fulminant hepatic failure
30. Orthotopic liver transplantation in fulminant and subfulminant hepatitis: The Paul Brousse experience
31. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure
32. Endogenous retroviruses in xenografts
33. Significance of middle molecules in the pathogenesis of hepatic encephalopathy
34. Clinical experience of postoperative hepatic failure treatment with pig or baboon liver cross-hemodialysis with an interposed membrane
35. Pilot-controlled trial of extracorporeal liver assist device in acute liver failure
36. L-ornithine-L-aspartate lowers hyperammonemia and prevents encephalopathy and brain edema in acute liver failure via a post-translational increase of muscle glutamine synthetase
37. Humoral injury in porcine livers perfused with human whole blood
38. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor
39. Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: A pre-clinical controlled trial
40. Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation
41. Perfusion system for the isolated porcine liver
42. Application of immunoapheresis for delaying hyperacute rejection during isolated xenogeneic pig liver perfusion
43. Impact of immunoadsorption on complement activation, immunopathology, and hepatic perfusion during xenogeneic pig liver perfusion
44. Platelet functions and haemostasis parameters in pigs: Absence of side effects of a procedure of general anaesthesia
45. Extracorporeal liver perfusion: Applications of an improved model for experimental studies of the liver
46. Plasma separation and bilirubin adsorption after complicated liver transplantation: A therapeutic approach to excessive hyperbilirubinemia
47. Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice
48. The Hepatix extracorporeal liver assist device: Initial clinical experience
49. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration
50. Evidence for retrovirus in miniature swine with radiation-induced leukemia or metaplasia
51. Type C virus production by a continuous line of pig oviduct cells (PFT)
52. Infection of human cells by an endogenous retrovirus of pigs
53. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells